Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
CA Lachowiez, N Long, J Saultz, A Gandhi… - Blood …, 2023 - ashpublications.org
Risk stratification in acute myeloid leukemia (AML) remains principle in survival
prognostication and treatment selection. The 2022 European LeukemiaNet (ELN) …
prognostication and treatment selection. The 2022 European LeukemiaNet (ELN) …
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
A Bataller, A Garrido, F Guijarro, G Oñate… - Blood …, 2022 - ashpublications.org
Abstract The 2017 European LeukemiaNet (ELN 2017) guidelines for the diagnosis and
management of acute myeloid leukemia (AML) have become fundamental guidelines to …
management of acute myeloid leukemia (AML) have become fundamental guidelines to …
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
C Rausch, M Rothenberg-Thurley, A Dufour… - Leukemia, 2023 - nature.com
Abstract The revised 2022 European LeukemiaNet (ELN) AML risk stratification system
requires validation in large, homogeneously treated cohorts. We studied 1118 newly …
requires validation in large, homogeneously treated cohorts. We studied 1118 newly …
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged< 60 years
AK Eisfeld, J Kohlschmidt, A Mims, D Nicolet… - Leukemia, 2020 - nature.com
Abstract The European LeukemiaNet (ELN) recommendations for diagnosis and
management of acute myeloid leukemia (AML) have become an important tool to assess …
management of acute myeloid leukemia (AML) have become an important tool to assess …
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
T Herold, M Rothenberg-Thurley, VV Grunwald… - Leukemia, 2020 - nature.com
Abstract The revised 2017 European LeukemiaNet (ELN) recommendations for genetic risk
stratification of acute myeloid leukemia have been widely adopted, but have not yet been …
stratification of acute myeloid leukemia have been widely adopted, but have not yet been …
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients …
Abstract The European LeukemiaNet (ELN) recently proposed a revised recommendation
for the diagnosis and management of acute myeloid leukemia (AML) in adults, recognized …
for the diagnosis and management of acute myeloid leukemia (AML) in adults, recognized …
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
H Döhner, E Estey, D Grimwade… - Blood, The Journal …, 2017 - ashpublications.org
The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study
K Mrózek, J Kohlschmidt, JS Blachly, D Nicolet… - Leukemia, 2023 - nature.com
Abstract Recently, the European LeukemiaNet (ELN) revised its genetic-risk classification of
acute myeloid leukemia (AML). We categorized 1637 adults with AML treated with …
acute myeloid leukemia (AML). We categorized 1637 adults with AML treated with …
Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the …
Purpose The current European LeukemiaNet (ELN) recommendations for acute myeloid
leukemia (AML) propose a new risk reporting system, integrating molecular and cytogenetic …
leukemia (AML) propose a new risk reporting system, integrating molecular and cytogenetic …
How I treat AML incorporating the updated classifications and guidelines
F El Chaer, CS Hourigan… - Blood, The Journal of the …, 2023 - ashpublications.org
Abstract The European LeukemiaNet recently revised both the clinical (2022) and
measurable residual disease testing (2021) guidelines for acute myeloid leukemia (AML) …
measurable residual disease testing (2021) guidelines for acute myeloid leukemia (AML) …